Need help? Order a test
news

Circulating tumour cells may predict breast cancer outcomes

Breast cancer is the second most common cancer worldwide and there were over 2 million new cases in 2018, according to the World Cancer Research Fund. So there is great research interest in understanding more about what determines how likely people with breast cancer are to survive, and to respond to treatment. Researchers at Cleveland […]

Read more
news

Liquid biopsies shed light on cancer drug resistance

It is not uncommon for people with cancer to have treatment with a drug that is initially effective at shrinking their tumour, only for it to grow back as the cancer cells in the tumour evolve and become resistant to the drugs. It is estimated that drug resistance and the resulting ineffectiveness of treatments are […]

Read more
news

Multi-cancer blood test can detect 26 cancers

In the first study of its kind, researchers have used a simple blood test to safely detect multiple cancers in nearly 10,000 women with undiagnosed cancer. In some cases, women who took the blood test were able to have treatment to potentially cure the cancer. The researchers at the Johns Hopkins Kimmel Cancer Center in […]

Read more

Global Presence

RGCC operates in 23 countries across the world, with bases in all five continents.

Find out more